Indication
Activated phosphoinositide 3-kinase delta syndrome
Activated phosphoinositide 3-kinase delta syndrome is a rare primary immunodeficiency and inborn error of immunity affecting both humoral and cellular components of the immune system. Read more about Activated phosphoinositide 3-kinase delta syndrome
1 drugs 1 manufacturers
Drugs that treat it
Common Activated phosphoinositide 3-kinase delta syndrome therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonActivated phosphoinositide 3-kinase delta syndrome is a rare primary immunodeficiency and inborn error of immunity affecting both humoral and cellular components of the immune system.
Caused by autosomal dominant gain-of-function variants in *PIK3CD* or loss-of-function variants in *PIK3R1*, the disorder leads to constitutive hyperactivation of the PI3K-Akt-mTOR signaling pathway in leukocytes.
Pathophysiologically, this results in progressive T- and B-cell dysregulation and lymphopenia, clinically manifesting in childhood as recurrent sinopulmonary and viral infections, bronchiectasis, nonmalignant lymphoproliferation, autoimmunity, and a heightened lifetime risk of lymphoid malignancies.
- nih.gov
Activated phosphoinositide 3-kinase delta syndrome is a rare primary immunodeficiency and inborn error of immunity affecting both humoral and cellular components of the immune system Pathophysiologically, this results in progressive T- and B-cell dysregulation and lymphopenia, clinically manifesting in childhood as recurrent sinopulmonary and viral infections, bronchiectasis, nonmalignant lymphoproliferation, autoimmunity, and a heightened lifetime risk of lymphoid malignancies
- nih.gov
Activated phosphoinositide 3-kinase delta syndrome is a rare primary immunodeficiency and inborn error of immunity affecting both humoral and cellular components of the immune system Caused by autosomal dominant gain-of-function variants in *PIK3CD* or loss-of-function variants in *PIK3R1*, the disorder leads to constitutive hyperactivation of the PI3K-Akt-mTOR signaling pathway in leukocytes
- usmedicine.com
Caused by autosomal dominant gain-of-function variants in *PIK3CD* or loss-of-function variants in *PIK3R1*, the disorder leads to constitutive hyperactivation of the PI3K-Akt-mTOR signaling pathway in leukocytes
- medlineplus.gov
Pathophysiologically, this results in progressive T- and B-cell dysregulation and lymphopenia, clinically manifesting in childhood as recurrent sinopulmonary and viral infections, bronchiectasis, nonmalignant lymphoproliferation, autoimmunity, and a heightened lifetime risk of lymphoid malignancies
Personalize your experience
Follow Activated phosphoinositide 3-kinase delta syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.